Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression.

Ghotbaddini M, Moultrie V, Powell JB.

J Cancer Treatment Diagn. 2018;2(5):11-16. doi: 10.29245/2578-2967/2018/5.1136. Epub 2018 Oct 9.


Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.

Ghotbaddini M, Cisse K, Carey A, Powell JB.

PLoS One. 2017 Jul 3;12(7):e0179844. doi: 10.1371/journal.pone.0179844. eCollection 2017.


The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells.

Ghotbaddini M, Powell JB.

Int J Environ Res Public Health. 2015 Jul 6;12(7):7506-18. doi: 10.3390/ijerph120707506.


Cancer-promoting and Inhibiting Effects of Dietary Compounds: Role of the Aryl Hydrocarbon Receptor (AhR).

Powell JB, Ghotbaddini M.

Biochem Pharmacol (Los Angel). 2014 Mar 8;3(1). doi: 10.4172/2167-0501.1000131.


The Aryl Hydrocarbon Receptor: A Target for Breast Cancer Therapy.

Powell JB, Goode GD, Eltom SE.

J Cancer Ther. 2013 Sep;4(7):1177-1186.


The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.

Richmond O, Ghotbaddini M, Allen C, Walker A, Zahir S, Powell JB.

PLoS One. 2014 Apr 22;9(4):e95058. doi: 10.1371/journal.pone.0095058. eCollection 2014.


Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.

Tran C, Richmond O, Aaron L, Powell JB.

Biochem Pharmacol. 2013 Mar 15;85(6):753-62. doi: 10.1016/j.bcp.2012.12.010. Epub 2012 Dec 22.

Supplemental Content

Loading ...
Support Center